General

Bad news for big pharma

Inexpensive 'polypill' can cut the risk of strokes and heart disease by 50 per cent

A new study by a Canadian researcher published it British medical journal The Lancet suggests that a cheap five-in-one combination “polypill” of aspirin and cholesterol and blood pressure-lowering drugs can cut the risk of strokes and heart disease by 50 per cent. If approved for wider use, the “polypill” would reduce the need of many patients to take multiple and expensive drugs to treat such illnesses. “These drugs are off-patent and cost pennies,” notes one health specialist.

The Guardian

Looking for more?

Get the best of Maclean's sent straight to your inbox. Sign up for news, commentary and analysis.